Tocqueville Asset Management L.P. Catalyst Biosciences, Inc. Transaction History

Tocqueville Asset Management L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$0.91 - $4.16 $45,572 - $208,332	-50,080 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$3.78 - $5.18 $17,010 - $23,310	-4,500 Reduced 8.24%	50,080 $206,000
Q2 2021 Aug 16, 2021	BUY	$4.1 - $5.33 $61,499 - $79,950	15,000 Added 37.9%	54,580 $236,000
Q1 2021 May 17, 2021	SELL	$4.93 - $7.15 $54,230 - $78,650	-11,000 Reduced 21.75%	39,580 $199,000
Q4 2020 Feb 16, 2021	BUY	$4.55 - $7.29 $230,139 - $368,728	50,580 New	50,580 $319,000

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Tocqueville Asset Management L.P., based on Form 13F filings with the SEC.

Stay updated on Tocqueville Asset Management L.P. with notifications on news.